Jordi Vila is full professor of Microbiology in School of Medicine in the University of Barcelona (UB), Head of the Department of Clinical Microbiology at Hospital Clínic de Barcelona and Research professor at the Institute of Global Health (ISGlobal) of Barcelona. He was a Scientific Officer of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) (2002-2009) and ESCMID Congress Programme director (2010-2014). He is currently the president of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and he leads the Antimicrobial Resistance Initiative and the Viral and Bacterial Infections Programme at the Barcelona Institute for Global Health (ISGlobal). Jordi Vila has published 450 articles in peer-reviewed journals, 45 book chapters and directed 22 doctoral theses. He has participated in several European Union projects and has coordinated one of them entitled “Translational Research on Combating Antimicrobial Resistance” (TROCAR). Jordi Vila’s research focuses on investigation of the molecular bases of antimicrobial resistance, mainly in multidrug-resistant Gram-negative bacteria; discovery and development of new antibacterial drugs; development of molecular tools for rapid diagnosis of infectious diseases including infection biomarkers.
He participates in MISTRAL project as Principal Investigator studying the impact of antiretroviral therapy in the gut bacterial resistome from a phenotypic approach.